What is Biocon Limited's latest revenue?

Biocon Limited reported revenue of ₹16,927 Cr in its latest annual results, per the filed results.

What is Biocon Limited's latest net profit?

Biocon Limited reported net profit of ₹369 Cr in its latest annual results, per the filed results.

What is Biocon Limited's return on equity?

Biocon Limited posted ROE of 1.2% and ROCE of 3.0% for its latest annual results, computed from filed statements.

What is Biocon Limited's operating margin?

Biocon Limited's operating margin was 18.2% in its latest annual results, derived from filed operating expenses.

How much did Biocon Limited's revenue grow year-on-year?

Biocon Limited's revenue changed 3.4% year-on-year in its latest annual results, per the filed results.

BIO

BIOCON

Name: Biocon Limited (BIOCON) quarterly results & financial statements
Creator: Upmazing

Biocon Limited

HealthcareNIFTY Midcap 150

ISIN INE376G01013F&O · no price band

—

Day

52W

MCap₹64,764 Cr

weakUpmazing Score

Open chart ↗

BIO

BIOCON

Biocon Limited

HealthcareNIFTY Midcap 150

ISIN INE376G01013F&O · no price band

—

Day

52W

MCap₹64,764 Cr

weakUpmazing Score

Open chart ↗

Biocon Limited (BIOCON) reported revenue of ₹4,336 Cr and net profit of ₹137 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.

BIOCON fundamentals, Fundamental score 35/100

The statements below are read from Biocon Limited’s filed results, 26 filed quarters and 12 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.

Latest: Q1 FY26-27 · filed Aug 6, 2026 · audited

Sales CAGR · 3Y+14.8%FY22 → FY25

Sales CAGR · 4Y+19.9%FY21 → FY25

PAT CAGR · 3Y−16.9%FY22 → FY25

PAT CAGR · 4Y−16.9%FY21 → FY25

Price · 1Y+11.4%EOD

Price CAGR · 3Y+14.2%EOD

Consolidated view — the full group. Biocon Limited's standalone figures are parent-only (₹625 cr), a fraction of the group.

Quarterly resultsConsolidated

₹ Cr	Sep2019	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026Latest	YoYlatest
Sales	1,572	1,694	1,745	1,857	1,842	1,761	1,840	2,174	2,409	2,140	2,320	2,941	3,774	3,423	3,462	3,954	3,917	3,433	3,590	3,821	4,417	3,942	4,296	4,173	4,517	4,336	+10.0%
	1,169	1,281	1,353	1,458	1,406	1,371	1,395	1,686	1,985	1,740	1,849	2,297	2,777	2,708	2,721	3,027	3,001	2,813	2,905	3,070	3,339	3,193	3,460	3,340	3,496	3,489	+9.3%
Operating profit	403	413	391	400	436	389	446	488	—	399	471	644	997	714	742	927	916	620	685	752	1,078	749	835	834	1,020	847	+13.1%
OPM %	25.6%	24.4%	22.4%	21.5%	23.7%	22.1%	24.2%	22.5%	—	18.7%	20.3%	21.9%	26.4%	20.9%	21.4%	23.4%	23.4%	18.1%	19.1%	19.7%	24.4%	19.0%	19.4%	20.0%	22.6%	19.5%	+0.5 pp
Other income	38.4	18.3	15.5	27.9	205	47.2	105	48.3	12.3	77.9	64.5	78.6	155	93.5	158	566	48.6	1,135	32.5	34.8	36.9	79.7	93.0	117	52.5	54.5	-31.6%
Interest	13.8	12.5	6.50	4.80	33.9	19.9	22.5	14.7	—	19.9	30.0	120	249	233	248	267	227	236	226	223	212	277	272	210	232	213	-22.9%
Depreciation	132	167	178	186	184	195	202	206	—	218	231	301	364	358	389	415	407	405	420	425	436	455	473	515	513	547	+20.3%
Profit before tax	354	249	223	236	366	166	206	269	549	240	257	30.1	537	217	239	832	322	1,146	98.4	156	487	96.9	171	-67.8	248	128	+31.7%
Tax %	28.3%	32.5%	12.3%	20.8%	19.0%	34.6%	22.5%	18.3%	10.7%	12.3%	57.2%	-15.9%	15.3%	16.0%	17.4%	6.6%	29.9%	24.8%	72.5%	48.0%	5.6%	7.9%	22.5%	n/a (loss)	19.8%	-7.2%	-15.2 pp
Net profit	216	168	195	187	296	108	160	220	284	167	81.8	-20.7	415	149	173	753	223	862	27.1	81.1	459	89.2	133	-51.8	199	137	+53.4%
EPS (₹)	1.82	1.26	1.43	1.42	2.13	0.71	1.16	1.57	—	1.21	0.39	-0.35	—	0.85	1.05	5.52	1.13	5.51	-0.13	0.21	2.88	0.26	0.66	1.08	0.79	0.87	+234.6%

One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split · n/a (loss) = tax rate undefined on a loss↔ scroll for earlier quarters

Revenue & net profit trend

last 20 quarters

RevenueNet profit

Revenue & net profit — Consolidated20 quarters

Segment results

Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.

Forensic checksauto-scanned from the filing

Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.

How results moved the priceEOD reaction on the session the market could trade the filing

Avg absolute result-day move ±2.5%· EPS surprise: no estimates source· 1 earlier quarter has no dated filing on record

Q1'27filed Wed 5 Aug 16:51 · first tradeable session Thu 6 Auggap +0.7%close +2.7%

Q4'26filed Thu 7 May 23:49 · first tradeable session Fri 8 Maygap −0.9%close −0.5%

Q3'26filed Thu 12 Feb 19:51 · first tradeable session Fri 13 Febgap −0.3%close +0.8%

Q2'26filed Tue 11 Nov 20:29 · first tradeable session Wed 12 Novgap +0.6%close +5.4%

Q1'26filed Thu 7 Aug 20:14 · first tradeable session Fri 8 Auggap −1.4%close −5.7%

Q4'25filed Thu 8 May 19:37 · first tradeable session Fri 9 Maygap −0.3%close −1.4%

Q3'25filed Thu 30 Jan 20:38 · first tradeable session Fri 31 Jangap −2.8%close +1.6%

Q2'25filed Wed 30 Oct 17:40 · first tradeable session Thu 31 Octgap −4.7%close −1.4%

Q4'24filed Thu 16 May 17:16 · first tradeable session Fri 17 Maygap −0.2%close +0.0%

Q3'24filed Thu 8 Feb 19:05 · first tradeable session Fri 9 Febgap −1.3%close −4.0%

Q2'24filed Fri 10 Nov 16:24 · first tradeable session Sun 12 Novgap +3.8%close +3.3%

Q1'24filed Thu 10 Aug 19:54 · first tradeable session Fri 11 Auggap −1.7%close −2.0%

Q4'23filed Tue 23 May 20:05 · first tradeable session Wed 24 Maygap +7.4%close +0.4%

Q3'23filed Tue 14 Feb 19:18 · first tradeable session Wed 15 Febgap −0.5%close +1.3%

Q2'23filed Mon 14 Nov 20:18 · first tradeable session Tue 15 Novgap +0.0%close −0.8%

Q1'23filed Wed 27 Jul 18:58 · first tradeable session Thu 28 Julgap −2.3%close −5.1%

Q4'22filed Thu 28 Apr 20:46 · first tradeable session Fri 29 Aprgap +0.1%close −2.2%

Q3'22filed Thu 20 Jan 22:01 · first tradeable session Fri 21 Jangap −0.1%close +3.5%

Q2'22filed Thu 21 Oct 23:18 · first tradeable session Fri 22 Octgap −0.9%close −6.1%

Q1'22filed Thu 22 Jul 23:35 · first tradeable session Fri 23 Julgap −2.7%close −1.2%

PeriodQ1 FY26-27BasisConsolidatedFiledAug 6, 2026Qualityaudited

Frequently Asked Questions

What is Biocon Limited's latest revenue?: Biocon Limited reported revenue of ₹16,927 Cr in its latest annual results, per the filed results.
What is Biocon Limited's latest net profit?: Biocon Limited reported net profit of ₹369 Cr in its latest annual results, per the filed results.
What is Biocon Limited's return on equity?: Biocon Limited posted ROE of 1.2% and ROCE of 3.0% for its latest annual results, computed from filed statements.
What is Biocon Limited's operating margin?: Biocon Limited's operating margin was 18.2% in its latest annual results, derived from filed operating expenses.
How much did Biocon Limited's revenue grow year-on-year?: Biocon Limited's revenue changed 3.4% year-on-year in its latest annual results, per the filed results.